Not Yet RecruitingNot Applicable

Impact Evaluation of the Therapeutic Initiative's Prescribing Portrait and Therapeutics Letter on Opioid Use by Dentists

Canada3,498 participantsStarted 2026-01-06

Plain-language summary

The aim of this study is to estimate the impact of providing personalized prescribing data and educational materials on opioid prescribing to dentists in British Columbia, Canada. The main research questions are: 1. What is the impact of an intervention on the use of opioids for dental pain? The intervention includes a personalized prescribing report (a "Portrait"), brief educational summary, and patient education materials; and 2. Does the impact of the intervention increase when dentists are also invited to attend facilitated audit-and-feedback group sessions and to develop a practice improvement plan? Using administrative health data, the prescribing of those in different combinations of materials in the Early Group will be compared to those in the Delayed Group to estimate the impact of the materials on prescribing by the dentists.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Dentists will be eligible to receive an individual prescribing Portrait if they meet all of the following criteria: * Registered with the British Columbia Medical Services Plan (MSP) as being in active practice; * Have a valid mailing address in British Columbia; and * Issued ≥10 prescriptions dispensed at community pharmacies between January 5, 2025 and January 5, 2026, as identified in PharmaNet claims data. Patients will be eligible for inclusion if they meet all of the following criteria: * Received an opioid prescription from an eligible dentist during the study period (January 6, 2026 to January 6, 2027); * The opioid prescription was issued by a dentist; and * Were continuously enrolled in the British Columbia Medical Services Plan (MSP) during the 12 months prior to the opioid prescription. Exclusion Criteria: Patients will be excluded if they meet any of the following criteria: * Had a medication dispensed under Plan P in the 12 months prior to the opioid prescription; or * Filled a prescription for opioid agonist therapy (OAT) within 180 days prior to the opioid prescription.

What they're measuring

The number of opioid prescriptions per dentist

Timeframe: From baseline to 12 months post interventions. The baseline is the 12-month period before the date when the prescriber is mailed the intervention bundle.

Total morphine milligram equivalents (MME) prescribed per dentist

Timeframe: From baseline to 12 months post interventions. The baseline is the 12-month period before the date when the prescriber is mailed the intervention bundle.

Trial details

NCT IDNCT07317869

SponsorUniversity of British Columbia

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-01-06

Contact for this trial

Ellen M Reynolds, MPA

1-250-208-4889 ellen.reynolds@ubc.ca

View on ClinicalTrials.gov More Clinical Audit trials

Plain-language summary

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

The number of opioid prescriptions per dentist

Timeframe: From baseline to 12 months post interventions. The baseline is the 12-month period before the date when the prescriber is mailed the intervention bundle.

Total morphine milligram equivalents (MME) prescribed per dentist

Timeframe: From baseline to 12 months post interventions. The baseline is the 12-month period before the date when the prescriber is mailed the intervention bundle.